Tumors Stocks List

Recent Signals

Date Stock Signal Type
2021-03-05 ARAY Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-03-05 ARAY Crossed Above 50 DMA Bullish
2021-03-05 BCEL Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-03-05 BCEL Crossed Above 20 DMA Bullish
2021-03-05 BCYC 50 DMA Resistance Bearish
2021-03-05 BCYC Wide Range Bar Range Expansion
2021-03-05 BCYC Pocket Pivot Bullish Swing Setup
2021-03-05 BCYC Lower Bollinger Band Walk Weakness
2021-03-05 BCYC Bullish Engulfing Bullish
2021-03-05 BIOC Lower Bollinger Band Walk Weakness
2021-03-05 BIOC Hammer Candlestick Bullish
2021-03-05 BOLT Hot IPO Pullback Bullish Swing Setup
2021-03-05 CGEM 20 DMA Support Bullish
2021-03-05 CGEM New Downtrend Bearish
2021-03-05 CGEM Calm After Storm Range Contraction
2021-03-05 CGEM Doji - Bullish? Reversal
2021-03-05 CNCE Pocket Pivot Bullish Swing Setup
2021-03-05 CNCE Lizard Bullish Bullish Day Trade Setup
2021-03-05 CNCE Lower Bollinger Band Walk Weakness
2021-03-05 CNCE Hammer Candlestick Bullish
2021-03-05 CNCE Doji - Bullish? Reversal
2021-03-05 CSBR Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-03-05 CSBR 20 DMA Support Bullish
2021-03-05 CSBR 50 DMA Support Bullish
2021-03-05 CSBR Doji - Bullish? Reversal
2021-03-05 ENLV Lizard Bullish Bullish Day Trade Setup
2021-03-05 ENLV Doji - Bullish? Reversal
2021-03-05 ENLV Hammer Candlestick Bullish
2021-03-05 FUSN New 52 Week Closing Low Bearish
2021-03-05 FUSN Lizard Bullish Bullish Day Trade Setup
2021-03-05 FUSN Hammer Candlestick Bullish
2021-03-05 GRTS MACD Bearish Centerline Cross Bearish
2021-03-05 GRTS 50 DMA Support Bullish
2021-03-05 GRTS Hammer Candlestick Bullish
2021-03-05 GRTS Lizard Bullish Bullish Day Trade Setup
2021-03-05 GRTS 1,2,3 Pullback Bullish Bullish Swing Setup
2021-03-05 GRTS Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-03-05 HARP MACD Bearish Signal Line Cross Bearish
2021-03-05 INBX MACD Bearish Signal Line Cross Bearish
2021-03-05 INBX Hammer Candlestick Bullish
2021-03-05 INBX NR7 Range Contraction
2021-03-05 POAI New Downtrend Bearish
2021-03-05 POAI Stochastic Reached Oversold Weakness
2021-03-05 POAI 200 DMA Support Bullish
2021-03-05 POAI Fell Below 50 DMA Bearish
2021-03-05 RAPT Lower Bollinger Band Walk Weakness
2021-03-05 SBTX Fell Below 50 DMA Bearish
2021-03-05 SBTX Expansion Pivot Sell Setup Bearish Swing Setup
2021-03-05 THC Upper Bollinger Band Walk Strength
2021-03-05 THC MACD Bullish Signal Line Cross Bullish
2021-03-05 THC Hammer Candlestick Bullish
2021-03-05 THC 20 DMA Support Bullish
2021-03-05 THC Bollinger Band Squeeze Range Contraction
2021-03-05 THC New 52 Week Closing High Bullish
2021-03-05 XLRN Lizard Bullish Bullish Day Trade Setup
2021-03-05 XLRN 50 DMA Support Bullish
2021-03-05 XLRN Hammer Candlestick Bullish
2021-03-05 XLRN Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-03-05 XLRN Doji - Bullish? Reversal

Recent News for Tumors Stocks

Date Stock Title
Mar 6 HARP The Week Ahead In Biotech (March 7-13): Conference Presentations And More Earnings
Mar 5 THC Tenet to Participate in Barclays Global Healthcare Conference
Mar 5 CSBR Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 11, 2021
Mar 4 CSBR Analysts Estimate Champions Oncology, Inc. (CSBR) to Report a Decline in Earnings: What to Look Out for
Mar 4 HARP Harpoon Therapeutics, Inc. (HARP) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
Mar 4 HARP Harpoon Therapeutics to Report Fourth Quarter 2020 Financial Results and Provide Corporate Update
Mar 4 SBTX How Much Are Silverback Therapeutics, Inc. (NASDAQ:SBTX) Insiders Spending On Buying Shares?
Mar 3 THC Encompass Health (EHC) Ties Up for Better Homehealth Care
Mar 3 GRTS Gritstone Oncology, Inc. (GRTS) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
Mar 3 THC Top-Ranked Select Medical's Stock Soars On Strong Profit Growth; Key Rating Bumped Up
Mar 3 RAPT RAPT Therapeutics to Participate in Two Investor Conferences in March
Mar 2 FUSN Fusion to buy Ipsen's IPN-1087 in pipeline expansion push
Mar 2 BIOC Biocept, Aegea Bio Ink COVID-19 Test Supply Agreement
Mar 2 CGEM Cullinan Oncology, Inc. to Participate in the H.C. Wainwright Global Life Sciences Conference
Mar 2 BIOC Biocept and Aegea Biotechnologies strike supply deal for COVID-19 assay kit
Mar 2 BIOC Aegea Biotechnologies Announces Supply Agreement with Biocept for New COVID-19 Test with the Ability to Distinguish Virus Strains and Quantify Viral Load
Mar 2 GRTS Gritstone to Present at the H.C. Wainwright Global Life Sciences Conference
Mar 2 FUSN Fusion Pharmaceuticals to Expand Pipeline with Acquisition of IPN-1087, a Small Molecule Targeting NTSR1, from Ipsen
Mar 1 XLRN Acceleron (XLRN) Q4 Loss Wider Than Expected, Revenues Beat
Mar 1 XLRN Citi reiterates buy, boosts price target of Acceleron shares

A neoplasm is a type of abnormal and excessive growth, called neoplasia, of tissue. The growth of a neoplasm is uncoordinated with that of the normal surrounding tissue, and it persists growing abnormally, even if the original trigger is removed. This abnormal growth usually (but not always) forms a mass. When it forms a mass, it may be called a tumor.
ICD-10 classifies neoplasms into four main groups: benign neoplasms, in situ neoplasms, malignant neoplasms, and neoplasms of uncertain or unknown behavior. Malignant neoplasms are also simply known as cancers and are the focus of oncology.
Prior to the abnormal growth of tissue, as neoplasia, cells often undergo an abnormal pattern of growth, such as metaplasia or dysplasia. However, metaplasia or dysplasia does not always progress to neoplasia. The word is from Ancient Greek νέος- neo ("new") and πλάσμα plasma ("formation", "creation").

More about Tumors
Browse All Tags